Actinogen Medical Ltd - Asset Resilience Ratio

Latest as of December 2024: 74.78%

Actinogen Medical Ltd (ACW) has an Asset Resilience Ratio of 74.78% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Actinogen Medical Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$19.02 Million

≈ $13.45 Million USD Cash + Short-term Investments

Total Assets

AU$25.43 Million

≈ $17.99 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Actinogen Medical Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see ACW total asset value.

Liquid Assets Composition Over Time

This chart breaks down Actinogen Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Actinogen Medical Ltd (ACW) long-term investment share to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$19.02 Million	74.78%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$19.02 Million	74.78%

Asset Resilience Insights

Very High Liquidity: Actinogen Medical Ltd maintains exceptional liquid asset reserves at 74.78% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Actinogen Medical Ltd Industry Peers by Asset Resilience Ratio

Compare Actinogen Medical Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	0.91%

Annual Asset Resilience Ratio for Actinogen Medical Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Actinogen Medical Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-06-30	33.86%	AU$7.22 Million ≈ $5.11 Million	AU$21.31 Million ≈ $15.08 Million	-13.35pp
2023-06-30	47.21%	AU$7.18 Million ≈ $5.08 Million	AU$15.21 Million ≈ $10.76 Million	-4.71pp
2022-06-30	51.92%	AU$12.10 Million ≈ $8.56 Million	AU$23.31 Million ≈ $16.49 Million	+13.28pp
2021-06-30	38.63%	AU$7.10 Million ≈ $5.02 Million	AU$18.38 Million ≈ $13.00 Million	+8.77pp
2020-06-30	29.87%	AU$3.56 Million ≈ $2.52 Million	AU$11.94 Million ≈ $8.45 Million	-17.21pp
2019-06-30	47.08%	AU$7.64 Million ≈ $5.40 Million	AU$16.22 Million ≈ $11.48 Million	-7.83pp
2018-06-30	54.90%	AU$9.90 Million ≈ $7.00 Million	AU$18.03 Million ≈ $12.75 Million	+15.83pp
2017-06-30	39.07%	AU$3.99 Million ≈ $2.82 Million	AU$10.21 Million ≈ $7.22 Million	+7.98pp
2016-06-30	31.09%	AU$4.03 Million ≈ $2.85 Million	AU$12.95 Million ≈ $9.16 Million	--

pp = percentage points

About Actinogen Medical Ltd

AU:ACW Australia Biotechnology

Market Cap

$130.44 Million

AU$184.35 Million AUD

Market Cap Rank

#18273 Global

#557 in Australia

Share Price

AU$0.06

Change (1 day)

-7.94%

52-Week Range

AU$0.03 - AU$0.07

All Time High

AU$0.18